Search research articles
Contact Us
Filters
Showing results (1-10 of 133) with videos related to
Page
of 14
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
May 8, 2018
Role of perioperative chemotherapy in soft-tissue sarcomas: It's time to end a never-ending story
A Italiano, E Stoeckle
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 24, 2016
Pulmonary sarcoidosis or post-immunotherapy granulomatous reaction induced by the anti-PD-1 monoclonal antibody pembrolizumab: the terminology is not the key point
S Cousin, A Italiano
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 19, 2017
Gougerot-Sjogren-like syndrome under PD-1 inhibitor treatment
D Teyssonneau, S Cousin, A Italiano
Pharmacology & Therapeutics
|
July 19, 2017
Toxicity profiles of immunotherapy
S Cousin, J Seneschal, A Italiano
Bulletin Du Cancer
|
May 21, 2010
[Chemotherapy options for patients with advanced soft-tissue sarcoma beyond anthracyclines]
A Italiano, M Toulmonde, B Bui-Nguyen
Bulletin Du Cancer
|
April 10, 2009
[Colorectal cancers: prognostic and predictive factors of response to treatment]
M-P Sablin, A Italiano, J-P Spano
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 10, 2023
WGS/WES-RNAseq compared to targeted NGS in oncology: is there something to unlock?
M Aldea, D Vasseur, A Italiano, et al.
Bulletin Du Cancer
|
June 16, 2010
[Adjuvant chemotherapy of adults soft tissue sarcomas]
B Bui-Nguyen, A Italiano, F Delva, et al.
JBR-BTR : Organe De La Societe Royale Belge De Radiologie (SRBR) = Orgaan Van De Koninklijke Belgische Vereniging Voor Radiologie (KBVR)
|
May 30, 2006
Linea alba tumoral (sarcomatous) hernia
P Y Marcy, O Hericord, A Italiano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 22, 2015
A clinical case of invasive lobular breast carcinoma with ERBB2 and CDH1 mutations presenting a dramatic response to anti-HER2-directed therapy
T Grellety, I Soubeyran, J Robert, et al.
Page
of 14
Search research articles
Search
Showing results (1-10 of 133) with videos related to
Sort By:
Page
of 14
European Journal of Cancer (Oxford, England : 1990)
|
May 8, 2018
Role of perioperative chemotherapy in soft-tissue sarcomas: It's time to end a never-ending story
A Italiano, E Stoeckle
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 24, 2016
Pulmonary sarcoidosis or post-immunotherapy granulomatous reaction induced by the anti-PD-1 monoclonal antibody pembrolizumab: the terminology is not the key point
S Cousin, A Italiano
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 19, 2017
Gougerot-Sjogren-like syndrome under PD-1 inhibitor treatment
D Teyssonneau, S Cousin, A Italiano
Pharmacology & Therapeutics
|
July 19, 2017
Toxicity profiles of immunotherapy
S Cousin, J Seneschal, A Italiano
Bulletin Du Cancer
|
May 21, 2010
[Chemotherapy options for patients with advanced soft-tissue sarcoma beyond anthracyclines]
A Italiano, M Toulmonde, B Bui-Nguyen
Bulletin Du Cancer
|
April 10, 2009
[Colorectal cancers: prognostic and predictive factors of response to treatment]
M-P Sablin, A Italiano, J-P Spano
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 10, 2023
WGS/WES-RNAseq compared to targeted NGS in oncology: is there something to unlock?
M Aldea, D Vasseur, A Italiano, et al.
Bulletin Du Cancer
|
June 16, 2010
[Adjuvant chemotherapy of adults soft tissue sarcomas]
B Bui-Nguyen, A Italiano, F Delva, et al.
JBR-BTR : Organe De La Societe Royale Belge De Radiologie (SRBR) = Orgaan Van De Koninklijke Belgische Vereniging Voor Radiologie (KBVR)
|
May 30, 2006
Linea alba tumoral (sarcomatous) hernia
P Y Marcy, O Hericord, A Italiano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 22, 2015
A clinical case of invasive lobular breast carcinoma with ERBB2 and CDH1 mutations presenting a dramatic response to anti-HER2-directed therapy
T Grellety, I Soubeyran, J Robert, et al.
Page
of 14